# Moderna, Inc.: Form 8-K, filed Oct 2, 2024

- Company: [Moderna, Inc.](/companies/mrna.md) (CIK 1682852)
- Form: 8-K
- Filed: 2024-10-02
- Accepted by EDGAR: Oct 2, 2024, 07:03 ET
- Period: 2024-09-28
- Accession: 0001682852-24-000052
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1682852/000168285224000052/mrna-20240928.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1682852/000168285224000052/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1682852/000168285224000052/mrna-20240928.htm

Filed Oct 2, 2024.
Source: SEC EDGAR, the filing index for accession 0001682852-24-000052. Last ingested by Listed: Nov 14, 2026, 18:43 ET. No prices; not investment advice.
